Based on a number of experiments it is concluded that the fluorescein labeled β-heptapeptide fluoresceinyl-NH-CS-(S)-β 3 hAla-(S)-β 3 hArg-(R)-β 3 hLeu-(S)-β 3 hPhe-(S)-β 3 hAla-(S)-β 3 hAla-(S)-β 3 hLys-OH translocates across lipid vesicle bilayers formed from DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine). The conclusion is based on the following observations: (i) addition of the peptide to the vicinity of micrometer-sized giant vesicles leads to an accumulation of the peptide inside the vesicles; (ii) if the peptide is injected inside individual giant vesicles, it is released from the vesicles in a time dependent manner; (iii) if the peptide is encapsulated within sub-micrometer-sized large unilamellar vesicles, it is released from the vesicles as a function of time; (iv) if the peptide is submitted to immobilized liposome chromatography, the peptide is retained by the immobilized DOPC vesicles. Furthermore, the addition of the peptide to calcein-containing DOPC vesicles does not lead to significant calcein leakage and vesicle fusion is not observed. The finding that derivatives of the β-heptapeptide (S)-β 3 hAla-(S)-β 3 hArg-(R)-β 3 hLeu-(S)-β 3 hPhe-(S)-β 3 hAla-(S)-β 3 hAla-(S)-β 3 hLys-OH can translocate across phospholipid bilayers is supported by independent measurements using Tb 3+ -containing large unilamellar vesicles prepared from egg phosphatidylcholine and wheat germ phosphatidylinositol (molar ratio of 9:1) and a corresponding peptide that is labeled with dipicolinic acid instead of fluorescein. The experiments show that this dipicolinic acid labeled β-heptapeptide derivative also permeates across phospholipid bilayers. The possible mechanism of the translocation of the particular β-heptapeptide derivatives across the membrane of phospholipid vesicles is discussed within the frame of the current understanding of the permeation of certain oligopeptides across simple phospholipid bilayers.
Introduction
Currently, there is considerable interest in peptides that are able to translocate across the membranes of biological cells, since such "cell penetrating peptides" (CPPs) are potentially interesting for delivering bioactive molecules into cells [1] [2] [3] [4] . It seems that the mechanism by which the peptides are taken up by the cells depends on the type of CPP and different internalization pathways may exist simultaneously [2] , although endocytosis appears to be the major route of uptake [4] . Furthermore, the importance of the chemical structure of the counter ions for efficient cell internalization has also been pointed out and experimentally demonstrated [5] .
One class of CPPs are α-oligoarginines [6] and β-oligoarginines [7] and corresponding derivatives thereof. In the latter case, uptake by 3T3 mouse fibroblasts [7] , HeLa cells and human keratinocytes [8] was found to occur for example in the case of peptide 1 (Fig. 1) , which is a β-decaarginine peptide derivative that contains a fluorescein group for visualization by fluorescence microscopy. In contrast, no cell uptake was observed for 3, the fluorescein derivative of the β-heptapeptide 2 ( Fig. 1) [8] . Like 1, β-peptide 3 also bears a fluorescein group, but overall 3 is considerably more hydrophobic than 1. Furthermore, 3 does not form a helix-or turnsecondary structure in solution [9] due to the altered configuration at the third β-amino acid ((R)-β 3 hLeu), in comparison to all other amino acids being in an (S) configuration. The same applies for peptides 2 and 4.
Preliminary experiments with giant unilamellar vesicles (GUVs) formed from POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) and POPG (1-palmitoyl-2-oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)]) at a molar ratio of 9:1 (POPC:POPG) indicated that the two peptides also behave differently if added to these types of membrane-mimicking systems [8] . While 1 bound to the negatively charged vesicle membrane, 3 appeared to pass across the vesicle bilayer into the interior of the vesicles [8] . Therefore, 3 seemed to be taken up by simple POPC vesicles but not by biological cells [7, 8] . These initial experimental findings in cell culture and vesicle studies may indicate at least the following. Either (i) the uptake of 3 by biological cells is not a simple diffusion of this peptide derivative across the lipid matrix of the membrane; or (ii) simple POPC/POPG vesicles are not adequate models of the lipid matrix of the membranes of the biological cells with which the peptide uptake was tested.
In any case, a strong binding of β-oligoarginines to negatively charged phospholipid bilayers as found for 1 has been confirmed in a series of independent mechanistic and thermodynamic measurements using submicrometer-sized vesicles, and a comparison with corresponding α-oligoarginines was carried out [10] . The binding data suggested that ∼70-75% of the total free energy of binding has non-electrostatic origin (hydrogen bonding and/or hydrophobic interactions) [10] .
In the present work, the focus is on peptide derivative 3 and the related dipicolinic acid derivative 4 ( Fig. 1 ), in comparison with peptide derivatives 1 and 5 ( Fig. 1) . In a series of independent experiments we particularly show that the two types of β-peptide derivatives (3 and 4 vs. 1 and 5) behave differently if brought in contact with zwitterionic or negatively charged vesicles. Evidence is presented that 3 and 4 permeate across DOPC (1,2-dioleoyl-snglycero-3-phospholcholine) and mixed egg phosphatidylcholine (egg PC)/wheat germ phosphatidylinositol (PI) bilayers, while there is no indication of bilayer permeation in the case of 1 or 5.
Materials and methods

Chemicals
1, 2-Dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1-palmitoyl-2-oleoly-snglycero-3-phosphocholine (POPC), N-NBD-PE (N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine), N-rhodamine-PE (N-(lissamine rhodamine B sulfonly)phosphatidylethanolamine) and egg phosphatidylethanolamine (egg PE) were purchased from Avanti Polar Lipids (Albaster, AL, USA). Egg phosphatidylcholine (egg PC) grade 1 and wheat germ phosphatidylinositol (PI) were purchased from Lipid Products (Nutfield, UK). Calcein was bought from Dojindo (Kumamoto, Japan). Melittin was from Sigma (St. Louis, MO, USA). TbCl 3 hexahydrate was purchased from Aldrich. Sepharose 4 B, Sephacryl S-1000 and Sephadex G-25 PD-10 were from Amersham Biosciences, Sweden. ANTS (8-aminonaphthalene 1,3,6-trisulfonic acid sodium salt) and DPX (p-xylylene bis(pyridinium) bromide) were from Molecular Probes (Indian City, OR, USA). All the other chemicals were of analytical grade. 
Peptide synthesis
The peptides 1, 2, 3, 5 and 6 were prepared as described previously [8, 11] . Peptide derivative 4 was synthesized as follows. In a first step, the preparation of Fmoc-protected β-heptapeptide bound to Wang resin was achieved by using Fmocprotected β-amino acids as obtained from Fluka (Switzerland) or Novabiochem (Switzerland). Esterification of Wang resin (300 mg, 1.1 mmol/g) and subsequent peptide synthesis was carried out according to our previously published procedure [8] to give 565 mg of resin-bound Fmoc-protected β-heptapeptide. A portion of the resin (125 mg) was Fmoc-deprotected using 20% piperidine in dimethylformamide (DMF) (4 ml, 4 × 5 min) under N 2 bubbling, and the resin was filtered and washed with DMF (4 ml, 5 × 1 min). The resin was then treated with a solution of pyridine-2,6-dicarboxylic acid monobenzyl ester [11] (54 mg, 0.21 mmol), HATU (=2-7-Aza-1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate) (76 mg, 0.20 mmol) and DIPEA (=N,N′-diisopropylethylamine) (71 ml, 0.42 mmol) in DMF (5 ml) and the suspension mixed by N 2 bubbling for 4 h. The resin was washed with DMF (5 ml, 3×1 min) and CH 2 Cl 2 (5 ml, 5 × 1 min) and completion of the coupling was confirmed with TNBS (2,4,6-trinitrobenzene sulfonic acid) [12] . The resin was then dried under high vacuum for 12 h. Cleavage of the peptide from the resin was carried out by suspending the dry peptide-resin in a solution of TFA/i-Pr 3 SiH/H 2 O (95:2.5:2.5, v/v/v, 10 ml) and mixing by N 2 bubbling for 4 h. The resin was removed by filtration, washed with TFA (2×), and the filtrate diluted with CH 2 Cl 2 (10 ml) and the volatiles removed under reduced pressure. The resulting oily residue was treated with cold Et 2 O to precipitate the crude benzyl-protected peptide. The benzylprotected DPA-peptide (DPA = dipicolinic acid = pyridine-2,6-dicarboxylic acid) was dissolved in MeOH (5 ml) under N 2 , and Pd/C (10% w/w) was added. The apparatus was evacuated and flushed with H 2 (3×), and the solution was stirred under H 2 (balloon) for 12 h. The solution was filtered through Celite, and the filtrate was concentrated under reduced pressure to give 53 mg of crude peptide. Purification of 25 mg of the crude peptide by RP-HPLC (25% 0.1% TFA in H 2 O, 75% MeCN for 5 min, 25-30% 0.1% TFA in H 2 O in 30 min, linear gradient) and subsequent lyophilization with a Helosicc cooling condenser and a high vacuum pump gave 7.1 mg of pure 4 as white TFA salt. For the RP-HPLC purification, a preparative C 18 -HPLC column (Nucleosil 100-7 C 18 , 250 mm × 21 mm) from Marchery-Nagel (Switzerland) was used at a flow rate of 10 ml/min with UV detection at 220 nm.
The + ; calc. 1023.5991). Analytical RP-HPLC was performed using a Nucleosil 100-5 C 18 column (250 mm × 4 mm) from Machery-Nagel (Switzerland) at a flow rate of 1 ml/min with UV detection at 220 nm. For MS, a IonSpec Ultima 4.7-T-FT Ion cyclotron resonance (ICR, HR-MALDI, in 2,5-dihydroxybenzoic acid matrix) spectrometer was used; data are given in m/z (% of basis peak).
Preparation of giant unilamellar vesicles (GUVs)
POPC and DOPC GUVs were prepared with the electroformation method [13] , originally developed by Angelova and Dimitrov [14] [15] [16] . The investigation chamber contained two parallel platinium wire electrodes (diameter 0.5 mm), separated at a distance of 3 mm.
POPC GUVs were prepared as follows: About 2 μl of a solution of POPC (0.25 mM) in diethyl ether:methanol (9:1, v/v) were applied onto each of the two platinum wires. After drying, 1 ml deionized water was added and an alternating electric field was applied at 1.2 V and 2 Hz for 30-50 min to hydrate the phospholipids and to form the giant vesicles.
The vesicles were observed with a Zeiss Axiovert 135 TV inverted microscope with a 20× objective with long distance Achroplan lenses and a DIC filter, equipped with a Hamamatsu C5810 CCD camera and a HB-50 mercury excitation light source and the Zeiss filter set no. 9 .
DOPC GUVs were prepared as follows: About 2 μl of a solution of DOPC (0.1 mM) in diethyl ether:methanol (9:1, v/v) were applied onto each of the two platinum wires. After drying, 1 ml deionized water was added and an alternating electric field was applied at 1.5 Vand 10 Hz for 120 min to hydrate the phospholipids and to form the giant vesicles. The alternating electric field was generated with a SG-4101 function generator from IWATSU Co. Ltd., Osaka, Japan.
The vesicles were observed with an Olympus IX-51-11 FL/PH-S fluorescence microscope and an ORCA-ER C4742-95 CCD camera from Hamamatsu Photonics.
Addition of peptides to POPC GUVs
A 2-μl aliquot of an aqueous solution of the peptide (100 μM or 200 μM) was added from a distance of 10-50 μm away from the target vesicle by using an Eppendorf 5242 microinjector, as described previously [8] .
Injection of peptides into DOPC GUVs
Aqueous solutions of the peptides (200 μM) were microinjected into individual GUVs, using a microinjector IM-300 (Narishige Co. Ltd., Tokyo, Japan) following the previously described method [13, 17, 18] . For each peptide, four independent measurements were carried out with target vesicles that had diameters above 100 μm. The injected volumes varied between ca. 5 and 20 picoliters [13] . The images taken were analyzed with the software Aqua Cosmos, version 2.5.
Preparation of DOPC large unilamellar vesicles (LUVs)
LUVs with an average diameter of ca. 100 nm were prepared by the extrusion technique [19] using a LiposoFast device from Avestin (Canada) [20] . A thin dried film containing 10 mg DOPC (13.4 μmol) was hydrated with 1 ml buffer solution (0.1 M Tris-HCl, 0.15 M NaCl, pH 7.5) by shaking for 60 min and then vortexed for 30 s at room temperature to yield a vesicle suspension containing mainly multilamellar vesicles. After freezing the sample in liquid nitrogen and thawing at room temperature (five times), the suspension was first passed through a 200-nm polycarbonate membrane (15×), and then through a 100-nm polycarbonate membrane (15×), to yield LUVs. The average hydrodynamic diameter of the vesicles was between 110 and 115 nm, as determined by dynamic light scattering measurements using a DLS-700Ar instrument from Otsuka Electric Co., Ltd., Osaka, Japan. The DOPC concentration in the final vesicle suspension was determined with an enzymatic assay kit (Test Wako-C) from Wako Pure Chemical Co. Ltd. (Osaka, Japan).
Calcein release experiments with DOPC LUVs
DOPC LUVs containing calcein (0.1 M) were prepared in a similar manner to that described above for LUVs in pure buffer solution, with the only difference being that the solution with which the lipids were hydrated was 0.1 M Tris-HCl, pH 7.5, containing 0.1 M calcein. Untrapped calcein molecules were removed from the calcein-containing vesicles by size exclusion chromatography using a Sepharose 4B column (diameter: 1 cm, length: 15 cm; applied sample volume: 0.5 ml), see [21] , and 0.1 M Tris-HCl, 150 mM NaCl, pH 7.5 as elution buffer. The fluorescence intensity of the vesicles containing entrapped calcein was measured and found to be low due to self-quenching [22, 23] .
To follow the release of entrapped calcein after peptide addition, a peptide solution was mixed with a DOPC LUV suspension to yield 0.1 mM DOPC and 10 μM peptide. The change in fluorescence intensity due to calcein release from the vesicles [23] was monitored with a FP6500 fluorescence spectrometer from Nihon Bunko, Japan. Excitation and emission wavelengths were set at 490 and 520 nm, respectively. The amount of calcein released after time t was calculated according to Eq. (1) RFð%Þ ¼ 100ðIðtÞ À Ið0ÞÞ=ðIðlÞ À Ið0ÞÞ ð1Þ
where RF is the percentage amount of calcein released, I(0), I(t) and I(∞) are the fluorescence intensities measured at the beginning of the experiment, at time t, and after addition of 3% triton X-100, respectively.
Peptide release experiments with DOPC LUVs
DOPC LUVs containing peptides were prepared in a similar manner to that described above for LUVs in pure buffer solution, but using as the lipid hydrating solution 0.1 M Tris-HCl, 0.15 M NaCl, pH 7.5 containing 10 μM peptide. Untrapped peptide molecules were removed from the peptide-containing vesicles by size exclusion chromatography using Sephacryl S-1000 (diameter: 1 cm, length: 15 cm; applied sample volume: 0.5 ml) and 0.1 M Tris-HCl, 150 mM NaCl, pH 7.5 as elution buffer. The peptide-containing LUV suspension was stored for 2 days at room temperature and then re-chromatographed (sample volume: 1 ml) to check for any released peptide molecules.
Immobilized liposome chromatography (ILC)
Lipid vesicles can be immobilized covalently or non-covalently on gel beads for use as a hydrophobic affinity matrix for HPLC systems [24, 25] . In the present work, DOPC LUVs were covalently immobilized on Sephacryl S-1000 gel beads, following the procedures described in the literature using LUVs containing 1 mol% egg PE [26] . Sephacryl S-1000 was activated with p-nitrophenyl chloroformate and reacted with the LUVs [26] . The gel beads were then packed into a HR5/5 glass column from Amersham Biosciences (Sweden) [21] . The inner diameter of the column was 0.5 cm and the length was 5.2 cm. The amount of phospholipids immobilized onto the gel beads was 2 μmol per mg gel, the flow rate was 0.25 ml/ min, 10 μl of a 0.5-μM peptide solution was injected onto the column, and 0.1 M Tris-HCl (pH 7.5) containing 0.15 M NaCl was used as eluent.
Fusion assays with DOPC LUVs
The possible fusion of DOPC LUVs upon peptide addition was investigated with three different fusion assays. While two of the assays were based on measuring the mixing of the aqueous contents of two separately prepared vesicle populations, the third assay was based on monitoring the mixing of lipids originally present in two different vesicle populations.
Cobalt (II)-calcein method
The assay was carried out as described previously [27, 28] . In brief, 0.1 mM DOPC LUVs containing the non-fluorescent cobalt(II)-calcein complex (internal concentration 0.8 mM) and 0.1 mM DOPC LUVs containing EDTA (internal concentration 1 mM) were mixed. After addition of 10 μM peptide, the fluorescence intensity was measured (λ ex =490 nm, λ em = 520 nm). If EDTA complexes Co 2+ , the sample becomes fluorescent. The extent of fusion can be calculated by using Eq. (2) Fusionð%Þ ¼ j100ðIðtÞ À Ið0ÞÞ=ðIðlÞ À Ið0ÞÞj ð2Þ
where I(t) and I(0) are the fluorescence intensities measured at time t and 0, respectively, and I(∞) is the fluorescence intensity measured after addition of triton X-100 (0.5 wt.%).
ANTS/DPX method
The assay was carried out as previously described [29] . In brief, 0.1 mM DOPC LUVs containing 12.5 mM ANTS and 20 mM NaCl, and 0.1 mM DOPC LUVs containing 45 mM DPX, 20 mM NaCl, 5 mM HEPES (4-(2-hydoxyethyl) piperazine-1-ethanesulfonic acid), pH 7.5 were first prepared separately. The eluent in the final size-exclusion chromatography step was 5 mM HEPES, 100 mM NaCl, pH 7.5. EDTA (1 mM) was added to the vesicles to yield a concentration of 0.1 mM. The peptide was then added at a concentration of 10 μM. The decrease in fluorescence intensity resulting from the formation of the ANTS/DPX complex (λ ex = 355 nm, λ em = 520 nm) was monitored and the extent of fusion was calculated by applying Eq. (2).
N-NBD-PE/N-rhodamine-PE resonance energy transfer assay
The assay was carried out as previously described [29] . LUVs at a concentration of 0.1 mM DOPC containing 1 mol% N-NBD-PE and LUVs at a concentration of 0.1 mM DOPC containing 1 mol% N-rhodamine-PE were prepared separately. Both vesicle preparations were mixed with unlabeled LUVs at a molar ratio of labeled to unlabeled vesicles of 1:4. Finally, equal volumes of the two 0.1-mM vesicle suspensions were mixed and 10-μM peptide was added. Immediately after mixing (t= 0), the fluorescence intensity was monitored (λ ex =460 nm, λ em =530 nm). If the lipids of the different sets of vesicles exchange, the energy released by NBD is transferred to rhodamine resulting in an increase in rhodamine fluorescence intensity. Quantitative lipid mixing was determined by using LUVs that contained 0.1 mol% of N-NBE-PE as well as 0.1 mol% N-rhodamine-PE.
Preparation of Tb
3 -containing egg PC/PI (9/1) LUVs
-containing lipid vesicles were prepared from TbCl 3 hexahydrate (0.2 mmol) and 100 mg egg PC/PI (9:1, molar ratio) by extrusion through 200 nm polycarbonate membranes, as described previously [30] . External Tb 3+ was separated from the vesicles on a Sephadex G-25 PD-10 desalting column by elution with 0.2 M NaCl. The concentration of Tb 3+ inside the aqueous pool of the vesicles was between 5 and 7 mM [30] . Tb 3+ -containing vesicles were used within a few hours.
The average size and the size distribution of the vesicle preparations were analyzed by dynamic light scattering with a Zetasizer 3000 HSA (from Malvern Instruments, Malvern, UK). Tb 3+ -containing vesicles showed an average mean hydrodynamic diameter between 140 and 180 nm.
Tb
3+ -based bilayer permeation assay
The entry kinetics of the peptides 4 and 5 into the Tb
3+
-containing aqueous interior of the vesicles were determined on a Synergy HT plate reader (from Bio-Tek Instruments, Winooski, VT, USA) [31] . The vesicle suspensions were diluted to 2-3 mg phospholipid/ml in 0.2 M Tris-HCl, pH 6.8. All solutions were equilibrated at 25°C. At time zero, 10 to 20 μl of 0.5 to 1 mM peptide solutions were added to the wells of a 96-well plate which each contained 200 μl of the diluted vesicle suspension. The total Tb 3+ concentration was ca. 0.1 mM and the peptide concentrations were between 20 and 100 μM. The samples were excited at 275 nm, and Tb
luminescence was recorded every 30 s at 545 nm with a time delay of 0.05 ms, a gate time of 1 ms, a cycle time of 20 ms and at 1 flash per cycle. The assays were run for 30 to 60 min. The apparent logarithmic permeation coefficient, log Perm app , was calculated from the luminescence vs. time curves, as described previously [31] .
The luminescence vs. time profiles were fitted with a bi-exponential function. The initial, fast phase, which reached about half of the fitted infinite luminescence, was used to calculate Perm app as shown in Eq. (3):
where k is the rate constant of the initial, fast phase and r is the hydrodynamic diameter of the vesicles, as determined by dynamic light scattering. The applicability conditions and further details of this procedure are discussed elsewhere [31] .
Circular dichroism (CD) measurement
CD spectra were recorded on either a Jasco J-710 or a Jasco J-820SFU spectropolarimeter from 195 to 250 nm at 25°C using 1 mm quartz cells. Measurements in methanol were carried out at 0.2 mM and smoothing of the spectra was done by using the Jasco software. Measurements in water were performed at 0.01 mM peptide and in the absence or presence of DOPC LUVs at a DOPC concentration of 0.1 mM. All spectra are normalized.
Results
Interaction of 1 and 3 with POPC GUVs and leakage of 3 from DOPC GUVs
In a series of preliminary measurements with negatively charged GUVs composed of POPC and POPG (9:1, molar ratio), it was previously found that the two fluorescent peptides 1 and 3 behave very differently if added in the external vicinity of a target vesicle [8] . The analysis of fluorescence light micrographs showed that the β-decaarginine derivative 1 binds to the vesicles without any evidence of permeation into the vesicle's interior under the experimental conditions used [8] . In contrast, externally added 3 appeared to translocate across the negatively charged bilayer into the interior of the vesicles [8] . If zwitterionic POPC GUVs were used without any added negatively charged lipid, there was again evidence that 3 permeated across the vesicle bilayer from the vesicle's exterior to the interior, although the uptake process seemed to be slightly slower than that observed with POPC:POPG (9:1) vesicles (data not shown). In contrast, no indication of peptide uptake and only weak binding to POPC GUVs was observed in the case of 1 (data not shown).
With DOPC GUVs, microinjection experiments were performed. A few picoliters of a 200-μM peptide solution were microinjected inside individual giant vesicles, and the fluorescence intensity of the targeted vesicle was monitored as a function of time after microinjection. The results obtained for 1 and 3 are shown in Fig. 2 . In the case of the β-decaarginine derivative 1, the fluorescence remained stable for at least 40 min (Fig. 2Ab and B , open square), indicating that the injected peptide did not leak out from the vesicle. In contrast, the fluorescence intensity of the vesicles into which peptide derivative 3 was added decreased with time ( Fig. 2Aa and B, filled circles) , indicating peptide leakage from the vesicles.
Leakage of 3 from DOPC LUVs
LUVs that contained 3 or 1 were first prepared at a concentration of 10 μM peptide and 13.4 mM DOPC. In a first approximation, one can assume that the concentration of the peptides inside the vesicles immediately after removing non-entrapped peptides was about 10 μM (assuming equal peptide distribution between vesicle interior and bulk aqueous phase during vesicle preparation). The vesicle suspensions were then stored at room temperature for 2 days and re-chromatographed with a Sephacryl S-1000 column. The collected fractions were analyzed for the presence of peptide. Fig. 3A (for 3) and B (for 1) show for both peptide derivative (a) the chromatograms obtained immediately after preparation in which non-entrapped peptides (2) were separated from the peptide-containing DOPC LUVs (1), and (b) the chromatogram of the pooled vesicle-fractions (1) that were stored for 2 days and then re-chromatographed. In the case of 3, free peptide molecules were present in the stored samples, indicating peptide leakage from the LUVs during storage. For 1, no leakage could be observed under the conditions used (no presence of free peptide in Fig. 3Bb ).
Immobilized liposome chromatography
DOPC LUVs were covalently bound to Sephacryl S-1000 gel beads [24] [25] [26] and the immobilized lipid vesicles were used as an insoluble matrix to study the affinity of the peptide derivatives 1 and 3 for the vesicles by the so-called "immobilized liposome chromatography" [25, 32] . Fig. 4 shows the elution profiles for 3 and 1 in comparison with glycine. While glycine and 1 were not retarded, both eluting after about 15 min, 3 clearly interacted with the immobilized vesicles and eluted after about 20 min, indicating a stronger association of 3 with DOPC vesicles than of 1.
Calcein release experiments
DOPC LUVs containing 0.1 M self-quenched calcein [22, 23] were prepared at a DOPC concentration of 13.4 mM and the release of the entrapped calcein upon external addition of the peptides 1 and 3 was investigated at pH 7.4 (0.1 M Tris-HCl, 0.1 M NaCl) with a total concentration of 0.1 mM DOPC and 10 μM peptide. Within the first 10 min after peptide addition to the vesicles, no significant calcein release could be observed. In contrast, upon addition of 10 μM melittin, a polypeptide known to permeabilize phospholipid bilayers [33] , 100% of the entrapped calcein was released after 3 min (Fig. 5) .
Vesicle fusion assays
Peptide derivatives 3 and 1 were tested for their vesicle fusion ability using DOPC LUVs (0.1 mM DOPC) and a peptide concentration of 10 μM. For this, three different assays were used, the cobalt(II)-calcein method [27, 28] , the ANTS/DPX method [29] , and the N-NBD-PE/N-rhodamine-PE resonance energy transfer assay [29] . While with the first two methods vesicle fusion resulting in mixing of aqueous contents can be monitored, with the third method vesicle fusion resulting in phospholipid mixing can be Fig. 3 . Encapsulation of 10 μM peptide derivatives 3 (A) and 1 (B) inside DOPC LUVs and peptide release from DOPC LUVs, as determined by size exclusion chromatography using a Sephacryl S-1000 column (diameter: 1 cm; height 15 cm). Elution buffer: 0.1 M Tris-HCl, 0.15 M NaCl, pH 7.5, fraction volume: 0.5 ml. The upper chromatograms (a) show the separation of peptide-containing vesicles (peak 1) from non-encapsulated peptide (peak 2), carried out after the encapsulation procedure (applied volume: 0.5 ml). The pooled fractions of peak 1 were stored for 2 days at room temperature and then applied (1 ml) onto the same column (bottom chromatograms (b)). recorded. With both peptides and with all three methods, no significant vesicle fusion was found under the conditions used (Table 1 ).
Entry of 4 into egg PC/PI (9/1) LUVs
To corroborate the observed phospholipid bilayer permeation capability of the β-heptapeptide derivative 3, the permeation behavior of 4 was also studied with a recently developed Tb 3+ -based permeation assay [11, 30, 31] . As shown in Fig. 6 , the luminescence of the entrapped Tb 3+ -ions increased with time after peptide addition to Tb 3+ -containing LUVs, indicating that 4 entered the egg PC/ PI (9:1, molar ratio) vesicles. The determined logarithmic apparent permeation coefficient, log Perm app , for 4 was −8.3± 0.1 (cm/s).
With egg PC LUVs, peptide uptake could neither be detected with 4, nor with 5 ( Fig. 1) (data not shown) .
CD measurements
The CD spectra of 2 and 6 measured at a concentration of 0.2 mM in methanol are shown in Fig. 7A . While 6 has a negative CD signal centered around 215 nm, in agreement with what has been found before in the case of 0.1 mM 6 [8] , the CD spectrum of peptide 2 is rather different, indicating that 2 does -containing LUVs composed of egg PC and wheat germ PI (molar ratio 9:1) at 25°C. Similar kinetic curves were also observed for peptide concentrations up to 100 μM. Lipid concentrations were between 2 and 3 mg/ml. Grey line: control in the absence of peptide. not fold to a 3 14 helix or a hair-pin turn in methanol. For the CD spectra characteristic for secondary structures, see [9] .
In the case of 1 and 3, the CD spectra were measured in aqueous solution in the absence and presence of DOPC LUVs, see Fig. 7B . In the case of 1, the CD spectrum in the presence of vesicles (b) is almost the same as in pure water (a), with a broad minimum around 220 nm. For 3, however, the presence of DOPC LUVs leads to a significant change in the CD spectrum (compare curves c and d in Fig. 7B ), indicating peptide vesicle interactions that lead to conformation changes of peptide 3.
Discussion
Despite there being no experimental evidence for the permeation of 3 across biological membranes [7, 8] , experiments with lipid vesicles indicate that this molecule can permeate across simple phospholipid bilayers present in the form of vesicles. In contrast, the β-decaarginine derivative 1, known to be taken up by biological cells [7, 8] , only binds to the surface of phospholipid vesicles, without any indication of a translocation across the bilayered vesicle membrane [8] .
The initial findings that 3 translocates across negatively charged GUVs composed of POPC and POPG (at a molar ratio of 9:1) [8] correlates with the observation that 4 enters negatively charged LUVs composed of egg PC and PI (9:1, molar ratio) (Fig. 6) . Independent of whether fluorescein or dipicolinic acid is covalently bound to the terminal amino group of the β-heptapeptide, the peptide permeates across negatively charged phospholipid bilayers. Since fluorescein and dipicolinic acid both are partially hydrophobic moieties, it may well be that these labels contribute to the observed uptake by the vesicles, although they may not be made responsible alone for the uptake: peptide derivative 1 -which bears a fluorescein group -is not taken up by the same type of vesicles. The determined logarithmic permeation coefficient for 4 (− 8.3 ± 0.1 (cm/s)) is similar to that of the much shorter hydrophobic β-tetrapeptide DPA-(R)-β 3 hVal-(S)-β 3 hAla-(R)-β 3 hVal-(R)-β 3 hVal-OH (log Perm app = − 8.3 ± 0.2 cm/s for egg PC LUVs, [11] ). Although 4 is longer and more hydrophilic than the β-tetrapeptide derivative to which comparison is made, both peptide derivatives permeate similarly. We originally thought that the permeation coefficient should decrease with an increase of peptide length and a decrease of its hydrophobicity, as previously discussed and demonstrated in the case of model α-peptides [34, 35] and β-peptides [11] . The positive charges of 4 may lead to an efficient permeation across net negatively charged bilayers because the peptide may interact electrostatically with PI that may not only affect the affinity to the membrane but also lead to a change in the peptide conformation on the membrane surface, resulting in a better translocation.
In the case of pure zwitterionic phosphatidylcholine bilayers, the permeation of 3 was less efficient but still detectable. In contrast, there was no measurable uptake of 4 by egg PC LUVs under the experimental conditions used. This qualitative difference in the behavior of 3 and 4 may be due to the different hydrophobicities of fluorescein and DPA, fluorescein being more hydrophobic than DPA.
In a series of experiments, the permeation behavior of 3 was studied with DOPC vesicles and a comparison was made with the behavior of 1 under comparable conditions. The physico-chemical properties of DOPC bilayers have been studied to some extent in the past. X-Ray and neutron diffraction data, for example, have shown that a DOPC bilayer has a "dynamic thickness" with respect to the transbilayer separation of water, suggesting that there must be transient contacts between the two cis-double bonds in DOPC and water [36] . It has been argued that the effective thickness of the hydrocarbon core of a DOPC bilayer can be less than 28.6 Å which lowers the energy barrier for the bilayer penetration and translocation of relatively polar molecules [36] .
All our experiments indicate that 3 can permeate across DOPC bilayers while 1 cannot. The results are summarized as follows: (i) if the peptide derivatives 3 or 1 were microinjected into DOPC GUVs, leakage of 3 from the vesicles was observed, while 1 remained trapped (Fig. 2) ; (ii) the same was observed with DOPC LUVs containing encapsulated peptides (Fig. 3) ; (iii) an affinity of 3 to DOPC vesicles was clearly demonstrated by immobilized liposome chromatography (Fig. 4) , while 1 did not show an affinity for the vesicles. The interaction of 3 with DOPC vesicles leads to a detectable change of the CD spectrum (Fig. 7B) .
Although the mechanism of bilayer translocation of 3 remains to be elucidated, there are at least two peptide properties that may be key factors for the observed peptide translocation: (i) the absence of secondary structure (no 3 14 helix or turn formation in solution [9] ), and (ii) "intermediate" hydrophobicity. A hydrophobic peptide is expected to partition from the vesicle's internal or external aqueous phase into the bilayer. However, if the peptide is too hydrophobic, it will remain trapped within the membrane, partitioning being in favor of the hydrophobic membrane domain. 3 seems to have an optimal hydrophobicity for bilayer translocation, while 1 is too hydrophilic. The presence of the fluorescein group in 3 may contribute to this optimal hydrophobicity [37] .
The proposed mechanism for the translocation of 3 across the bilayers of phospholipid vesicles is based on the partitioning of 3 between the aqueous phase of the system (either outside of the vesicles or inside) and the hydrophobic phospholipid membrane. The actual driving force for the translocation of 3 across the phospholipid bilayers is therefore the concentration gradient that determines the flux of 3 (considering Ficks' first law).
As shown before, the addition of convenient counter ions may possibly help in bringing highly charged peptides like 1 from one side of the membrane to the other [38] . Based on studies on guanidinium-rich α-oligopeptides, the group of Wender [39] proposed that the translocation of peptides with positively charged arginine side chains is mediated by the formation of bidentate hydrogen bonds with a hydrogen bond acceptor functionality on the surface of the cells. The ion pair thus formed partitions into the bilayer, followed by a migration across the membrane according to the transmembrane potential [39] . This hypothesis is similar to the mechanism described by the group of Matile [38] .
Conclusion
As a conclusion drawn from previous studies on the translocation of a number of different oligopeptides across phospholipid vesicle membranes or across planar bilayer membranes (Table 2) , there are one or more than one of the following four mechanistic aspects that are currently assumed to play an important role for efficient translocation: (i) pore formation that leads to leaking vesicles; (ii) formation of a complex between the peptide and the lipids that results in peptide uptake through the formation of a short-lived "pore"; (iii) role of transmembrane potential, possibly induced by the initial binding of the peptide to that half of the bilayer that is exposed to the peptide; (iv) fusion of the vesicles induced by the peptide. In the case of penetratin and its derivatives, the situation is not so clear as apparently contradicting results have been obtained for different lipid systems and experimental conditions used (Table 2) .
Concerning the effect of CPPs on vesicle leakage and transient pore formation, it has been shown in the case of Tp10 (transportan 10, an analog to transportan containing 21 amino acids) that calcein leakage from POPC vesicles is dependent on whether the free peptide is used (Tp10) or a peptide derivative, i. e. Tp10 with a cargo [40] . In the case of Tp10 and cargo-loaded Tp10, it is suggested that uptake by biological cells occurs via two pathways, No evidence of "pore" formation (no calcein release) [49] Carboxyfluorescein-labeled penetratin (n = 16) POPC/POPG (3:1); SUVs, LUVs, GUVs; 100 mM glucose, 10 mM KCl, 0.1 mM EDTA, pH ∼ 5.5
No evidence of peptide translocation [50] Penetratin analogs PenArg (n = 17) and PenLys (n = 17)
POPC/POPG (6:4); LUVs; 10 mM HEPES, 5 mM NaOH, 1 mM EDTA, 100 mM NaCl, pH 7. Peptide translocation observed across GUVs but not LUVs [51] Penetratin (n = 16) DOPC/DOPG (various molar ratios); SUVs and LUVs; 10 mM Tris, 0.5 mM EDTA, pH 7.8
"Electroporation-like" mechanism proposed for DOPC/DOPG b 1, according to which the asymmetrical peptide distribution between outer and inner surfaces causes a transmembrane potential; no evidence of vesicle fusion Importance of the presence of a transmembrane pH gradient (acidic inside the LUVs) for efficient peptide translocation from the inside to the outside [53] Penetratin (n = 16) and other polybasic peptides (n = 6) Different phospholipid mixtures; LUVs The uptake mechanism seems to depend on the system used; peptide translocation dependent on bilayer composition; presence of transbilayer potential important (K + inside, Na + outside the LUVs, use of valinomycin); minimal disturbance of the bilayer integrity (no calcein release); no evidence of vesicle fusion [54] Penetratin (n = 16) POPC/POPG (3:1); SUVs; 10 mM phosphate buffer, 154 mM NaF (pH 7.4)
No evidence for peptide translocation across the bilayers [55] endocytosis and direct membrane interactions, the latter pathway being more likely of importance in the case of Tp10 containing small hydrophobic cargos [40] . Our study shows that 3 does not form large pores under the conditions used (no calcein leakage). Furthermore, vesicle fusion was not observed. It therefore seems that 3 simply diffuses across DOPC bilayers.
Recently, it has been proposed that the physico-chemical translocation of certain CPPs and antimicrobial peptides across lipid bilayers may occur via a similar mechanism [41] . One quantitative difference within the different types of peptides belonging to the two classes of "membrane active peptides" [41] remains, however, the extent of pore formation. In this regard, buforin-2 ( Table 2 ) behaves similar to 3: uptake by vesicles without extensive dye leakage.
Since there is no indication that 3 is efficiently taken up by biological cells -in contrast to 1 [8] , we must conclude that mechanisms other than simple lipid bilayer permeation alone may be crucial for peptide uptake in living cells [7, 8] .
